Should I Buy BRZE? BRZE 2026 Analysis

Should You Buy Braze Inc (BRZE) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

17.790

1 Day change

0.34%

52 Week Range

43.890

Analysis Updated At

2026/02/04

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

BRZE is not a good buy right now for an impatient buyer: the chart is in a strong downtrend and momentum is still deteriorating, despite extreme oversold readings.
The RSI (6) ~10 suggests a bounce is possible, but price is already below/near key support (~19.60), increasing risk of a continued slide toward ~17.78 before a durable reversal.
Options positioning is mildly bullish (more calls vs puts by OI), but IV is extremely elevated, signaling uncertainty and making directional timing harder.
Hedge funds are buying, but insiders are aggressively selling, which is a meaningful near-term negative.

Intellectia Proprietary Trading Signals

AI Stock Picker: no signal on given stock today.
SwingMax: No signal on given stock recently.

Technical Analysis

Trend: Bearish (SMA_200 > SMA_20 > SMA_5 confirms sustained downtrend).
Momentum: MACD histogram -0.594 and negatively expanding → downside momentum is still strengthening.
Oscillator: RSI_6 = 10.426 (extremely oversold) → short-term bounce potential, but oversold can persist in strong downtrends.
Levels: Pivot 22.555 (far overhead), Resistance 25.509 / 27.333.
Support: S1 19.602 (current pre-market ~18.98 is below/around this), next support S2 17.778 → technically vulnerable if no quick reclaim above ~19.6–20.

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Sentiment (positioning): Open interest put/call = 0.53 → more call OI than put OI (moderately bullish positioning).
Sentiment (flow): Volume put/call = 0.88 with calls 187 vs puts 164 → slightly more call activity.
Volatility: 30D IV 78.43%, IV percentile 90.8 → options are pricing large moves / elevated uncertainty.
Activity: Today’s volume vs 30D avg 35.03 and open interest elevated (today vs OI avg 143.91) → heightened speculation/positioning around the name.

Technical Summary

Sell

Buy

Positive Catalysts

- Fundamentals: Latest quarter shows strong top-line growth (+25.51% YoY revenue) and improving losses (net income and EPS less negative).
- Institutional behavior: Hedge funds are buying (buying amount +105.34% last quarter).
- Street view still broadly constructive: multiple firms maintain Buy/Overweight ratings with targets well above the current price.

Neutral/Negative Catalysts

- Technicals: Downtrend + worsening MACD suggests sellers still control the tape.
- Support risk: Trading at/below S1 (~19.60) increases probability of a move toward ~17.78 if the stock fails to reclaim support quickly.
- Insider activity: Insiders are selling aggressively (selling amount +743.41% last month).
- No near-term news catalysts: No news in the last week, reducing the chance of an immediate sentiment reversal.
- Multiple compression narrative: Piper flagged “seat-compression and vibe coding narratives” potentially capping software multiples (pressure on valuation/expectations).

Financial Performance

Latest quarter: 2026/Q3.
Revenue: $190.842M, +25.51% YoY (growth remains strong).
Profitability trend: Net income -35.998M (improved 28.97% YoY); EPS -0.33 (improved 22.22% YoY) → losses narrowing.
Margin: Gross margin 67.18% (down 3.77% YoY) → some pressure on unit economics versus last year, worth monitoring if it persists.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Recent trend: Analysts remain mostly Buy/Overweight, but price targets were cut recently (more cautious on multiples even while staying positive on the company).
Notable changes:
- Piper Sandler (2026-02-02): PT cut $50 → $30, keeps Overweight (more conservative valuation view).
- Goldman Sachs (2026-01-28): PT cut $55 → $45, keeps Buy (still constructive).
- Wells Fargo (2026-01-05): added to Tactical Ideas List, Overweight, PT $45.
Wall Street pros: accelerating growth narrative (prior beats/raises), improving margins longer-term, strong category positioning.
Wall Street cons: sector/multiple pressure and AI-disruption narratives impacting valuation, plus near-term sentiment hit from target cuts.

16 Analyst Rating

Wall Street analysts forecast BRZE stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BRZE is 45 USD with a low forecast of 38 USD and a high forecast of 53 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

16 Buy

0 Hold

0 Sell

Strong Buy

Current: 17.730

Low

Averages

High

Current: 17.730

Low

Averages

High

Piper Sandler

Overweight

NULL

downgrade

$50 -> $30

AI Analysis

2026-02-02

Reason

Piper Sandler

Price Target

$50 -> $30

AI Analysis

2026-02-02

downgrade

Overweight

NULL

Reason

Piper Sandler lowered the firm's price target on Braze to $30 from $50 and keeps an Overweight rating on the shares following a transfer of coverage. The firm downgraded three names and cut price targets across the platforms and apps group, saying "seat-compression and vibe coding narratives could set a ceiling on multiples." Piper is not making a call on the Q4 reports. Rather, the analyst has mixed views on the software space despite share declines in the past 12 months. The firm expects continued "pessimism" around software and recommends investors focus on the hyperscaler, consumption and vertical sub-sectors. Piper's top picks are Microsoft and ServiceTitan.

Goldman Sachs

Buy

downgrade

$55 -> $45

2026-01-28

Reason

Goldman Sachs

Price Target

$55 -> $45

2026-01-28

downgrade

Buy

Reason

Goldman Sachs lowered the firm's price target on Braze to $45 from $55 and keeps a Buy rating on the shares. Software M&A activity is expected to accelerate in 2026, driven by compressed public valuations and the structural advantages of software businesses, including distribution, domain expertise, data moats, and brand equity, the analyst tells investors in a research note This could enable value creation through cross-portfolio synergies, acquisitions of top private-market technologies, and leveraging SaaS incumbents at more attractive multiples, the firm says.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for BRZE

Unlock Now

BRZE Should I Buy

BRZE Should I Buy

Should You Buy Braze Inc (BRZE) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch